LENSAR, Inc.
Qualité des données : 100%
LNSR
NASDAQ
Manufacturing
Measuring & Analyzing Instruments
5,70 €
▲
0,24 €
(4,40%)
Cap. Boursière: 67,07 M
Prix
5,55 €
Cap. Boursière
67,07 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—
Quick Summary
Points Clés
Revenue grew 14,11% annually over 5 years — strong growth
Negative free cash flow of -14,91 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 4,87%
Capital efficient — spends only 0,14% of revenue on capex
Croissance
Revenue Growth (5Y)
14,11%
Au-dessus de la moyenne du secteur (1,82%)
Revenue (1Y)9,24%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
N/A
ROIC-51,91%
Net Margin-58,66%
Op. Margin-42,06%
Sécurité
Debt / Equity
N/A
Current Ratio1,24
Interest CoverageN/A
Valorisation
PE (TTM)
-1,96
En dessous de la moyenne du secteur (-1,48)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Manufacturing (1366 pairs)
Comparaison Sectorielle
vs médiane du secteur Manufacturing (1366 pairs)| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -2,0 | -1,5 |
| P/B | — | 1,6 |
| ROE % | — | -53,6 |
| Net Margin % | -58,7 | -41,5 |
| Rev Growth 5Y % | 14,1 | 1,8 |
| D/E | — | 0,3 |
Objectif de Cours des Analystes
2 analystes
Buy
Actuel
5,70 €
Objectif
8,50 €
7,00 €
8,50 €
10,00 €
Prévisions
P/E Prévisionnel
-8,03
BPA Prévisionnel
-0,71 €
CA Est.
76,56 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2027 |
-0,71 €
-0,71 € – -0,71 €
|
76,56 M | 1 |
| FY2026 |
-0,08 €
-0,08 € – -0,08 €
|
63,07 M | 1 |
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| 2026 Q2 |
-0,27 €
-0,27 € – -0,27 €
|
14,99 M | 1 |
| 2026 Q1 |
0,49 €
0,49 € – 0,49 €
|
13,43 M | 1 |
Surprises de Résultats
Derniers 4 trimestres
| Trimestre | BPA Est. | BPA Réel | Surprise |
|---|---|---|---|
| Q42025 | -0,10 € | -0,11 € | -7,8% |
| Q32025 | -0,08 € | -0,11 € | -37,3% |
| Q22025 | -0,08 € | -0,10 € | -29,1% |
| Q12025 | -0,16 € | -0,06 € | +58,8% |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 9,24% | Revenue Growth (3Y) | 17,72% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 14,11% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 58,44 M | Net Income (TTM) | -34,28 M |
| ROE | N/A | ROA | -48,76% |
| Gross Margin | N/A | Operating Margin | -42,06% |
| Net Margin | -58,66% | Free Cash Flow (TTM) | -14,91 M |
| ROIC | -51,91% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 1,24 |
| Interest Coverage | N/A | Asset Turnover | 0,83 |
| Working Capital | 8,70 M | Tangible Book Value | -31,33 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -1,96 | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | 1,15 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -22,24% | ||
| Market Cap | 67,07 M | Enterprise Value | 59,43 M |
| Per Share | |||
| EPS (Diluted TTM) | -2,87 | Revenue / Share | 4,83 |
| FCF / Share | -1,23 | OCF / Share | -1,23 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | 0,14% | FCF Conversion | 43,51% |
| SBC-Adj. FCF | -17,85 M | Growth Momentum | -4,87 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 58,44 M | 53,49 M | 42,16 M | 35,36 M | 34,46 M |
| Net Income | -34,28 M | -31,40 M | -14,38 M | -19,91 M | -19,60 M |
| EPS (Diluted) | -2,87 | -2,73 | -1,31 | -1,96 | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | -24,58 M | -10,67 M | -12,23 M | -20,18 M | -19,65 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 5,62 M | 5,33 M | 6,14 M | 11,81 M | 12,36 M |
| SG&A Expenses | 45,16 M | 26,49 M | 26,10 M | 27,17 M | 23,89 M |
| D&A | — | — | — | — | — |
| Interest Expense | — | — | — | — | 1,34 M |
| Income Tax | — | — | — | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 71,43 M | 66,30 M | 69,59 M | 55,84 M | 66,47 M |
| Total Liabilities | 83,67 M | 47,65 M | 22,41 M | 13,86 M | 11,59 M |
| Shareholders' Equity | -26,02 M | 4,86 M | 33,43 M | 41,98 M | 54,88 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 12,97 M | 16,26 M | 20,62 M | 14,67 M | 31,64 M |
| Current Assets | 46,77 M | 41,98 M | 46,44 M | 33,72 M | 44,81 M |
| Current Liabilities | 40,57 M | 15,00 M | 11,63 M | 11,42 M | 8,71 M |
{"event":"ticker_viewed","properties":{"ticker":"LNSR","listing_kind":"stock","pathname":"/stocks/lnsr","exchange":"NASDAQ","country":"US"}}